help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2479
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/7/4238    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stefan, N.
Right arrow Articles by Fritsche, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stefan, N.
Right arrow Articles by Fritsche, A.
Related Collections
Right arrow Metabolism
Right arrow Lipid
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 7 4238-4243
Copyright © 2005 by The Endocrine Society

Liver Fat and Insulin Resistance Are Independently Associated with the –514C>T Polymorphism of the Hepatic Lipase Gene

Norbert Stefan, Silke Schäfer, Fausto Machicao, Jürgen Machann, Fritz Schick, Claus D. Claussen, Michael Stumvoll, Hans-Ulrich Häring and Andreas Fritsche

Department of Internal Medicine, Division of Endocrinology, Metabolism, and Pathobiochemistry (N.S., S.S., F.M., H.-U.H., A.F.), and Section on Experimental Radiology (J.M., F.S., C.D.C.), University of Tübingen, D-72076 Tübingen, Germany; and Department of Internal Medicine (M.S.), University of Leipzig, 100920 Leipzig, Germany

Address all correspondence and requests for reprints to: Norbert Stefan, M.D., Department of Internal Medicine, Division of Endocrinology, Metabolism, and Pathobiochemistry, Otfried-Müller-Strasse 10, D-72076 Tübingen, Germany. E-mail: norbert.stefan{at}med.uni-tuebingen.de.

Context: Liver fat predicts insulin resistance in humans. So far, there is not much information on genetic determinants of liver fat. Hepatic lipase is a liver-specific enzyme that regulates lipid metabolism.

Objective: First, our object was to investigate whether the functional –514C>T polymorphism of the hepatic lipase gene is associated with liver fat content and with insulin sensitivity. Second, because this polymorphism displays gene-nutrient interactions, we assessed gene-gene interactions with the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-{gamma}2 on liver fat content and insulin sensitivity.

Design and Methods: Cross-sectional data from a total of 1070 nondiabetic subjects were analyzed. Insulin sensitivity was estimated from a 75-g oral glucose tolerance test. A subgroup of 115 subjects underwent measurements of liver fat.

Results: The –514C>T polymorphism of the hepatic lipase gene was associated with higher liver fat content (P = 0.005) and lower insulin sensitivity (P = 0.02), both after adjustment for age, gender, and percentage of body fat. This was independent of serum adiponectin concentrations (P = 0.01 and 0.03). However, there was an interaction of the –514C>T polymorphism with the Pro12Ala variant on liver fat (P = 0.09) and insulin sensitivity (P = 0.01). Subjects carrying the –514C>T polymorphism had higher liver fat content and were insulin resistant only before the background of the Pro/Pro genotype of the Pro12Ala polymorphism.

Conclusions: The –514C>T polymorphism of the hepatic lipase gene is associated with higher liver fat content and lower whole-body insulin sensitivity. However, these effects are modulated by the common Pro12Ala polymorphism in peroxisome proliferator-activated receptor-{gamma}2. These findings may be relevant for intervention strategies to prevent increase in liver fat content and insulin resistance.




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kotronen and H. Yki-Jarvinen
Fatty Liver: A Novel Component of the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 27 - 38.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Kotronen, J. Westerbacka, R. Bergholm, K. H. Pietilainen, and H. Yki-Jarvinen
Liver Fat in the Metabolic Syndrome
J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3490 - 3497.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
T. J. Orchard, T. Costacou, A. Kretowski, and R. W. Nesto
Type 1 diabetes and coronary artery disease.
Diabetes Care, November 1, 2006; 29(11): 2528 - 2538.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society